These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 23404503)
21. Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression. Rivera O; Sharma M; Dagar S; Shahani N; Ramĺrez-Jarquĺn UN; Crynen G; Karunadharma P; McManus F; Bonneil E; Pierre T; Subramaniam S Cell Mol Life Sci; 2024 Apr; 81(1):169. PubMed ID: 38589732 [TBL] [Abstract][Full Text] [Related]
22. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. Liang Q; Deng H; Li X; Wu X; Tang Q; Chang TH; Peng H; Rauscher FJ; Ozato K; Zhu F J Immunol; 2011 Nov; 187(9):4754-63. PubMed ID: 21940674 [TBL] [Abstract][Full Text] [Related]
23. The B-box1 domain of PML mediates SUMO E2-E3 complex formation through an atypical interaction with UBC9. Bregnard T; Ahmed A; Semenova IV; Weller SK; Bezsonova I Biophys Chem; 2022 Aug; 287():106827. PubMed ID: 35667129 [TBL] [Abstract][Full Text] [Related]
24. Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein Ligation. Streich FC; Lima CD Methods Mol Biol; 2018; 1844():169-196. PubMed ID: 30242710 [TBL] [Abstract][Full Text] [Related]
25. A mechanistic view of the role of E3 in sumoylation. Tozluoğlu M; Karaca E; Nussinov R; Haliloğlu T PLoS Comput Biol; 2010 Aug; 6(8):. PubMed ID: 20865051 [TBL] [Abstract][Full Text] [Related]
26. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Morris JR; Boutell C; Keppler M; Densham R; Weekes D; Alamshah A; Butler L; Galanty Y; Pangon L; Kiuchi T; Ng T; Solomon E Nature; 2009 Dec; 462(7275):886-90. PubMed ID: 20016594 [TBL] [Abstract][Full Text] [Related]
27. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation. Sohn SY; Hearing P Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6725-30. PubMed ID: 27247387 [TBL] [Abstract][Full Text] [Related]
29. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications. Sohn SY; Hearing P mBio; 2019 Feb; 10(1):. PubMed ID: 30808699 [TBL] [Abstract][Full Text] [Related]
30. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro. Parker JL; Ulrich HD Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485 [TBL] [Abstract][Full Text] [Related]
31. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. Boggio R; Passafaro A; Chiocca S J Biol Chem; 2007 May; 282(21):15376-82. PubMed ID: 17392274 [TBL] [Abstract][Full Text] [Related]
32. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus. Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T J Virol; 2017 May; 91(10):. PubMed ID: 28250117 [TBL] [Abstract][Full Text] [Related]
34. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression. Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423 [TBL] [Abstract][Full Text] [Related]
35. The transcription factor Krox20 is an E3 ligase that sumoylates its Nab coregulators. García-Gutiérrez P; Juárez-Vicente F; Gallardo-Chamizo F; Charnay P; García-Domínguez M EMBO Rep; 2011 Sep; 12(10):1018-23. PubMed ID: 21836637 [TBL] [Abstract][Full Text] [Related]
36. Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1. Marteijn JA; van der Meer LT; van Emst L; van Reijmersdal S; Wissink W; de Witte T; Jansen JH; Van der Reijden BA Blood; 2007 Nov; 110(9):3128-35. PubMed ID: 17646546 [TBL] [Abstract][Full Text] [Related]
37. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212 [TBL] [Abstract][Full Text] [Related]
38. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation. Weger S; Hammer E; Engstler M Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784 [TBL] [Abstract][Full Text] [Related]